Preexercise breakfast ingestion versus extended overnight fasting increases postprandial glucose flux after exercise in healthy men. by Edinburgh,  R.M. et al.
Durham Research Online
Deposited in DRO:
21 November 2019
Version of attached ﬁle:
Published Version
Peer-review status of attached ﬁle:
Peer-reviewed
Citation for published item:
Edinburgh, R.M. and Hengist, A. and Smith, H.A. and Travers, R.L. and Koumanov, F. and Betts, J.A. and
Thompson, D. and Walhin, J.-P. and Wallis, G.A. and Hamilton, D.L. and Stevenson, E.J. and Tipton, K.D.
and Gonzalez, J.T. (2018) 'Preexercise breakfast ingestion versus extended overnight fasting increases
postprandial glucose ﬂux after exercise in healthy men.', American journal of physiology - endocrinology and
metabolism., 315 (5). E1062-E1074.
Further information on publisher's website:
https://doi.org/10.1152/ajpendo.00163.2018
Publisher's copyright statement:
Licensed under Creative Commons Attribution CC-BY 4.0: c© the American Physiological Society.
Additional information:
Use policy
The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or charge, for
personal research or study, educational, or not-for-proﬁt purposes provided that:
• a full bibliographic reference is made to the original source
• a link is made to the metadata record in DRO
• the full-text is not changed in any way
The full-text must not be sold in any format or medium without the formal permission of the copyright holders.
Please consult the full DRO policy for further details.
Durham University Library, Stockton Road, Durham DH1 3LY, United Kingdom
Tel : +44 (0)191 334 3042 | Fax : +44 (0)191 334 2971
http://dro.dur.ac.uk
RESEARCH ARTICLE
Preexercise breakfast ingestion versus extended overnight fasting increases
postprandial glucose flux after exercise in healthy men
Robert M. Edinburgh,1 Aaron Hengist,1 Harry A. Smith,1 Rebecca L. Travers,1 Francoise Koumanov,1
James A. Betts,1 Dylan Thompson,1 Jean-Philippe Walhin,1 Gareth A. Wallis,2 D. Lee Hamilton,3,5
Emma J. Stevenson,4 Kevin D. Tipton,3 and Javier T. Gonzalez1
1Department for Health, University of Bath, Bath, United Kingdom; 2School of Sport, Exercise and Rehabilitation, University
of Birmingham, Birmingham, United Kingdom; 3Physiology, Exercise and Nutrition Research Group, University of Stirling,
Stirling, United Kingdom; 4Human Nutrition Research Centre, Institute of Cellular Medicine, Newcastle University,
Newcastle-upon-Tyne, United Kingdom; and 5School of Exercise and Nutrition Sciences, Deakin University, Victoria, Australia
Submitted 23 April 2018; accepted in final form 2 August 2018
Edinburgh RM, Hengist A, Smith HA, Travers RL, Koumanov
F, Betts JA, Thompson D, Walhin JP, Wallis GA, Hamilton DL,
Stevenson EJ, Tipton KD, Gonzalez JT. Preexercise breakfast
ingestion versus extended overnight fasting increases postprandial
glucose flux after exercise in healthy men. Am J Physiol Endocrinol
Metab 315: E1062–E1074, 2018. First published August 14, 2018;
doi:10.1152/ajpendo.00163.2018.—The aim of this study was to char-
acterize postprandial glucose flux after exercise in the fed versus
overnight fasted state and to investigate the potential underlying
mechanisms. In a randomized order, twelve men underwent breakfast-
rest [(BR) 3 h semirecumbent], breakfast-exercise [(BE) 2 h semire-
cumbent before 60 min of cycling (50% peak power output)], and
overnight fasted exercise [(FE) as per BE omitting breakfast] trials.
An oral glucose tolerance test (OGTT) was completed after exercise
(after rest on BR). Dual stable isotope tracers ([U-13C] glucose
ingestion and [6,6-2H2] glucose infusion) and muscle biopsies were
combined to assess postprandial plasma glucose kinetics and intra-
muscular signaling, respectively. Plasma intestinal fatty acid binding
(I-FABP) concentrations were determined as a marker of intestinal
damage. Breakfast before exercise increased postexercise plasma
glucose disposal rates during the OGTT, from 44 g/120 min in FE {35
to 53 g/120 min [mean (normalized 95% confidence interval)] to 73
g/120 min in BE [55 to 90 g/120 min; P 0.01]}. This higher plasma
glucose disposal rate was, however, offset by increased plasma glu-
cose appearance rates (principally OGTT-derived), resulting in a
glycemic response that did not differ between BE and FE (P  0.11).
Plasma I-FABP concentrations during exercise were 264 pg/ml (196
to 332 pg/ml) lower in BE versus FE (P  0.01). Breakfast before
exercise increases postexercise postprandial plasma glucose disposal,
which is offset (primarily) by increased appearance rates of orally
ingested glucose. Therefore, metabolic responses to fed-state exercise
cannot be readily inferred from studies conducted in a fasted state.
breakfast; exercise; glycemia; insulin sensitivity; metabolism
INTRODUCTION
Postprandial glycemia is a strong predictor of future mor-
tality and morbidity. Even in people without diabetes, those
with greater blood glucose excursions after feeding are at an
increased risk of cardiovascular disease (47, 48). This glycemic
response to food ingestion is dictated by blood glucose kinetics
(i.e., the balance between the rates of glucose appearance into
blood and glucose disposal from blood into peripheral tissues).
Exercise potently increases glucose disposal from the blood
into skeletal muscle (52), and regular exercise is therefore
recommended as a lifestyle strategy to improve glycemic
control.
Habitual responses to exercise and nutrition are, however,
the culmination of not only chronic adaptations but also the
acute effects of each exposure to these daily behaviors (5, 6,
22). For example, each bout of exercise potently stimulates
postexercise insulin sensitivity and muscle glucose uptake
(52). However, despite increases in blood glucose disposal
rates, endurance-type exercise does not always reduce post-
prandial glucose excursions in the postexercise period (20,
54). The finding that postprandial blood glucose concentra-
tions are not lowered after exercise is because when exercise
is performed (at least in the fasted state), the increase in
postprandial blood glucose disposal after exercise can be
offset—and even superseded— by increases in both endog-
enous and meal-derived blood glucose appearance rates
(34, 54).
Although fasting before laboratory trials is common to
control for baseline metabolic status, these conditions may
preclude the application of findings to situations most repre-
sentative of daily living. For example, most people living in
developed countries spend the majority of a typical day in the
postprandial state (13, 55). Therefore, most eating occasions
and exercise sessions will take place in the context of this
postprandial situation (23). It has previously been shown by
others that plasma glucose fluxes during exercise (16), and by
us that plasma glucose concentrations after exercise (24), are
elevated by preexercise feeding. However, the effect of prior
feeding on postexercise plasma glucose flux has never, to our
knowledge, been assessed. Therefore, there is a distinct lack of
understanding regarding postprandial glucose kinetics under
scenarios that are most representative of daily living, and it
may not be valid to generalize existing observations of exercise
in the fasted state. Moreover, an understanding of the under-
lying mechanisms responsible for any differences in postpran-
dial glucose flux after exercise, with prior feeding versus
fasting, is still required.
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This study therefore aimed to characterize postprandial
plasma glucose kinetics after 1) breakfast and rest (BR), 2)
breakfast and exercise (BE), and 3) overnight fasted-state
exercise (FE), while also exploring potential mechanisms (in-
tramuscular signaling and markers of intestinal damage) to
explain any differences in glucose flux between these condi-
tions.
MATERIALS AND METHODS
Ethical approval. All trials were undertaken at the University of
Bath (Bath, UK) in accordance with the Declaration of Helsinki. The
study was approved by the National Health Service South-West
Research Ethics Committee (reference no. 15/SW/0006) and regis-
tered at clinicaltrials.gov as no. NCT02258399. Written, informed
consent was obtained from all participants before their participation.
Study design. This study was a randomized crossover design
(randomization performed by J.T.G with Research Randomizer ver-
sion 3.0, https://www.randomizer.org/). Preliminary testing was fol-
lowed by three trials (separated by 7 days), namely, BR, BE, and
FE. A schematic for the study protocol is shown in Fig. 1. For all
trials, participants arrived at the laboratory after a 12- to 14-h
overnight fast. In BR, a porridge breakfast was consumed, followed
by 3 h of rest, and then a 2-h oral glucose tolerance test (OGTT). In
BE, the same breakfast was consumed before 2 h of rest and 60 min
of cycling before the OGTT. In FE, breakfast was omitted but the trial
otherwise replicated BE. By necessity of design (food intake/exercise)
the intervention was open label. Within-laboratory testing conditions
were not different across the trials [(mean SD) ambient temperature
(23.7 0.5°C on BR, 23.7 0.6°C on BE, 23.6 0.7°C on FE) and
barometric pressure (734  5 mmHg on BR, 736 6 mmHg on BE,
736  5 mmHg on FE); all P  0.05].
Participants. Twelve healthy and physically active men (self-
reported as regular exercisers engaging in at least 30 min of exercise
a minimum of 3 times per week) were recruited from Bath and North
East Somerset between May and November 2015. Participant char-
acteristics are shown in Table 1. Exclusion criteria included any
history of metabolic disease or conditions that may have posed undue
personal risk to the participant or introduced bias to the study.
Preliminary testing. Participants were asked to refrain from stren-
uous physical activity for 24 h before preliminary testing but were
asked to otherwise maintain their normal physical activity behaviors.
They abstained from alcoholic and caffeinated drinks for 24 h before
this visit. Food intake ceased at 2000 on the evening before testing,
and participants fasted overnight (minimum 12 h), consuming only
water (ad libitum) during this period. In addition, they were asked to
consume 568 ml of water at least 1 h before testing and to void
immediately before arriving at the laboratory. Upon arrival, the
participant’s stature was measured (Frankfurt plane) to the nearest 0.1
cm using a stadiometer (Seca Ltd., Birmingham, UK). Body mass was
recorded to the nearest 0.1 kg (only light clothing permitted) using
electronic weighing scales (BC543 Monitor, Tanita, Tokyo, Japan). A
Fig. 1. Protocol schematic. An oral glucose tolerance test was conducted after breakfast followed by rest (BR), breakfast followed by exercise (BE), or extended
overnight fasting followed by exercise (FE). Dual stable isotope tracers ([U-13C] glucose ingestion and [6,6-2H2] glucose infusion) and muscle biopsies were
combined to assess postprandial plasma glucose kinetics and intramuscular signaling, respectively. Wmax, maximum power output.
Table 1. Participant characteristics
Characteristic Value
Age (years) 23 (3)
Stature (cm) 179.8 (4.4)
Body mass (kg) 76.3 (7.9)
Body mass index (kg/m2) 23.6 (2.90)
Fat mass (kg)† 10.6 (3.7)
Fat Mass Index (kg/m2)† 3.26 (1.12)
Body fat (%)† 14 (4)
Fat free mass (kg)† 65.5 (6.4)
V˙ O2peak (l/min)* 4.00 (0.72)
V˙ O2peak (ml·kg1·min1)* 53 (10)
Peak power output (W) 317 (67)
HRMAX (beats/min) 189 (10)
Data are presented as means and (standard deviation). n  12. HRMAX, max
heart rate; V˙ O2peak, peak oxygen uptake. *n  11, because of technical
difficulties with the breath-by-breath analysis during one participant’s prelim-
inary testing; †derived by dual-energy X-ray absorptiometry.
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whole-body dual energy X-ray absorptiometry scan was completed to
quantify fat and fat-free mass (Discovery, Hologic, Bedford, UK).
Participants then performed an incremental cycling exercise test at
a self-selected cadence on an electronically braked ergometer (Excali-
bur Sport, Lode Lode Groningen, Netherlands). They were permitted
to adjust the saddle and handlebar heights to their preferred position,
which were replicated for cycling during the exercise trials. The initial
exercise intensity was 50 W, and this was increased by 50 W every 4
min for 4 stages. Thereafter, the intensity was increased by 20 W
every min until volitional exhaustion. Heart rate (Polar Electro Oy,
Kempele, Finland) and continuous breath-by-breath measurements
were recorded throughout (TrueOne2400, ParvoMedics, Sandy). Vol-
ume and gas analyzers were calibrated with a 3-l calibration syringe
(Hans Rudolph, Kansas City) and a calibration gas (balance nitrogen
mix; 16.04% O2, 5.06% CO2; BOC Industrial Gases, Linde AG,
Munich, Germany), respectively. Peak power output was calculated as
the work rate of the last completed stage, plus the fraction of time
spent in the final noncompleted stage, multiplied by the work rate
increment. Peak oxygen uptake (V˙ O2peak) was calculated as the
highest average V˙ O2 over a rolling 30-s period.
Main trials. Participants refrained from strenuous physical activity,
alcohol, and caffeine for 24 h before all trials. They recorded the
composition of their evening meal on the day before the first main trial
and replicated this meal for subsequent trials in accordance with
procedures for standardizing postprandial glucose tolerance testing
(10). This pretrial standardization protocol has been previously shown
to be effective at producing overnight fasted muscle glycogen con-
centrations, liver glycogen concentrations, and intramyocellular lip-
ids, which are standardized across multiple trial days in a similar
population (21). To help ensure physical activity standardization,
participants completed a physical activity diary and wore a physical
activity monitor (Actiheart, Cambridge Neurotechnology, Papworth,
UK) for 24 h before all trials (pretrial 24-h physical activity energy
expenditure [(mean SD) 988  500 kcal on BR, 1,022 521 kcal
on BE, 992 313 kcal on FE; all P  0.05; n  9].
Participants arrived at the laboratory at 0800 1 h following a 12-
to 14-h overnight fast, and this arrival time was replicated for the
subsequent trials. They were asked to void, and all further urine
samples were collected for the remainder of the trial to allow for
urinary nitrogen excretion to be estimated from urine urea concentra-
tions. Participants then placed their dominant hand into a heated-air
box (Mass Spectrometry Facility; The University of Vermont &
University of Vermont Medical Center, Burlington, VT) set to 55°C.
After 20 min of rest, an intravenous catheter (BD Venflon Pro, BD,
Helsingborg, Sweden) was fitted into a heated dorsal hand vein
(retrograde), and a 10-ml baseline blood sample was drawn before a
5-min expired gas sample was collected. On the first main trial for
each participant (see Fig. 1), a baseline muscle sample was taken from
the vastus lateralis to allow for an assessment of the pathways
involved in exercise and insulin signaling in the muscle [5= AMP-
activated protein kinase (AMPK), acetyl-CoA carboxylase (ACC),
protein kinase B (herein refered to as Akt2), and Akt substrate of 160
kDa (AS160).
In BE and BR, a porridge breakfast was then consumed within 10
min (3 h pre-OGTT) and in FE, participants were allowed water only.
The breakfast was 72 g of instant refined oats (Oatso Simple Golden
Syrup, Quaker Oats) and 360 ml of semiskimmed milk (Tesco),
providing 431 kcal of energy [(1,803 kJ) 65 g carbohydrate, 11 g fat,
19 g protein]. The breakfast was high carbohydrate (57% of energy
intake) and had a high glycemic index [oatmeal, made from mix
(Quaker Oats) has a glycemic index of 69 (17)], as is commonly
consumed in developed countries. Because of the coingestion of milk,
this breakfast would produce a high insulinemic response (38, 46).
Breakfast consumption (or omission on FE) was followed by 2 h of
rest, where participants remained in a semirecumbent position, com-
pleting resting activities (e.g., watching television), with expired gas
samples collected every 60 min. After 1 h and 40 min of rest (1 h and
20 min pre-OGTT), a catheter was inserted into an antecubital vein
(the contralateral arm to the one used for blood sampling). A primed
infusion of [6,6-2H2]glucose was initiated and continued for the
remaining within-laboratory component of the trial (Cambridge Iso-
tope Laboratories, MA; prime: 13.5 mol/kg; infusion: 0.35
mol·kg1·min 1). After 20 min (60 min pre-OGTT) and on BE and
FE only participants began 60 min of cycling at 50% peak power
output on an ergometer (Lode Corival, Lode B.V., Groningen, Neth-
erlands). The cadence was self-selected (replicated for both exercise
trials), and the power output was monitored via a computerized
system. In BR, participants remained rested in the semirecumbent
position during this period. Expired gas samples were collected every
15 min, and blood samples were collected at 40 and 50 min of exercise
(20 and 10 min pre-OGTT). Immediately after exercise (or after rest
in BR) a muscle sample was taken from the vastus lateralis. Then a
2-h OGTT was completed, with arterialized blood sampled at 10-min
intervals and expired gas sampled every 60 min. The OGTT was 73
g of glucose (81 g of dextrose monohydrate when corrected for water
content; Myprotein, Northwich, UK) and 2 g of [U-13C]glucose (99%;
Cambridge Isotope Laboratories, MA) to allow the rate of appearance
of the orally ingested glucose (RaOGTT) to be assessed. A final muscle
sample was taken post-OGTT (OGTT 120 min).
Tracer approach, blood sampling, and analysis. A dual-tracer
approach was employed, where the tracer infusion rate was doubled
during exercise (on BE and FE) to account for an expected increase in
endogenous glucose production (1) and reduced to 80% of baseline at
OGTT 20 min (all trials) to account for an expected suppression of
endogenous glucose production after oral glucose ingestion (9). This
approach reduces changes in the tracer-to-tracee ratio, thereby per-
mitting more accurate estimations of glucose kinetics (4). Arterialized
blood was sampled from a heated dorsal hand vein at baseline at
60-min intervals during the initial 2-h rest period, at 40 and 50 min of
the exercise period (or after rest in BR), and at 10-min intervals during
the OGTT. Whole blood was dispensed into ethylenediaminetet-
raacetic acid-coated tubes (BD, Oxford, UK), which were first cen-
trifuged (4°C and 3,500 g) for 10 min (Heraeus Biofuge Primo R,
Kendro Laboratory Products Plc., UK) to obtain plasma. The plasma
was then dispensed into 0.5-ml aliquots and immediately frozen at
20°C before longer-term storage at 80°C.
Plasma glucose [intra-assay coefficient of variation (CV) 3.2%;
interassay CV 3.8%], lactate (intra-assay CV 1.0%; interassay CV
4.8%), and triglyceride (intra-assay CV 1.4%; inter-assay CV 4.0%)
concentrations were measured using an automated analyzer (Daytona,
Randox Laboratory, Crumlin, UK) as per the manufacturer’s instruc-
tions. Plasma insulin concentrations were measured using a commer-
cially available ELISA kit (Mercodia AB, Uppsala, Sweden; intra-
assay CV 5.7%; interassay CV 9.9%). Plasma intestinal fatty acid
binding protein (I-FABP) concentrations were measured as a marker
of intestinal cell damage using a commercially available ELISA kit
(Hycult Biotech; intra-assay CV 6.0%). Plasma nonesterified fatty
acid (NEFA) concentrations were determined using an enzymatic
colorimetric assay (WAKO Diagnostics; intra-assay CV 8.9%; inter-
assay CV 10.4%). For all of these analyses, all plasma samples were
analyzed in batch after all sample collection was completed and for a
given participant all samples (from the three trials) were run on the
same plate.
Plasma [U-13C]glucose and [2H2]glucose enrichments were deter-
mined by gas chromatography-mass spectrometry (GC, Agilent
6890N; MS, Agilent 5973N; Agilent Technologies, Stockport, UK).
Plasma glucose was extracted using methanol-chloroform and hydro-
chloric acid, dried under nitrogen gas, and then derivatised using the
heptofluorobuyric acid method as previously described (30). The
glucose derivative was acquired by selected ion monitoring at mass-
to-charge ratios 519, 521, and 525 for [12C]-, [6,6-2H2]-, and
[U-13C]glucose, respectively. Glucose enrichments of [13C] and [2H2]
in plasma were determined using standard curves for [13C] and [2H2]
glucose, and enrichments were expressed relative to those at 519
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(M  0). The baseline sample was used for every trial to account for
background isotopic plasma enrichments. To reduce any impact of
analytical variability on calculations of glucose kinetics, glucose and
enrichment data were curve fitted as previously described (63).
Muscle sampling and analysis. Muscle samples were collected
from the vastus lateralis under local anesthesia (~5 ml of 1% lido-
caine, Hameln Pharmaceuticals Ltd., Brockworth, UK). Samples were
taken from a 3–5-mm incision at the anterior aspect of the thigh with
a 5-mm Bergstrom biopsy needle technique adapted for suction (57).
Samples were immediately extracted from the needle and frozen in
liquid nitrogen before longer-term storage at 80°C. The order of
dominant or nondominant leg was counterbalanced across trials for
the OGTT 0- and 120-min samples. Samples were taken from separate
skin incision sites, with these 2 cm proximal to any previous
incision on the same leg (59). For the OGTT 0-min sample [after
exercise (or after rest in BR)] the incision was made before cycling
(BE and FE) and closed with Steristrips to allow for an immediate
sample to be taken after exercise.
Frozen wet tissue (20–30 mg) was freeze-dried, powdered, and
dissected free of visible blood and connective tissue and added to
ice-cold lysis buffer [50 mM Tris (pH 7.4), 150 mM NaCl, 0.5%
sodium deoxycholate; 0.1% SDS and 0.1% Nonidet P-40] with a
protease (Thermo Scientific) and phosphatase inhibitor cocktail (Mil-
lipore). Samples were homogenized with a dounce homogenizer (~40
passes), incubated for 60 min at 4°C with rotation, and centrifuged for
10 min (4°C and 20,000 g). The protein content of the resultant
supernatant was measured via a bicinchoninic acid protein assay kit
(Thermo Scientific). For Western blots, an equal amount of protein
(40 g) was loaded per lane for each sample and separated using
SDS-PAGE on Tris-glycine SDS-polyacrylamide gels (7% for phos-
phorylated (p)-AMPKThr172, total AMPK, p-ACCSer79, and total
ACC, 10% for p-AktSer473 and total Akt2, and 8% for p-AktThr308,
p-AS160Thr642, and total AS160). Gels were electro-blotted using a
semidry transfer onto a nitrocellulose membrane. Membranes were
washed in Tris-buffered saline (0.09% NaCl, 100 mM Tris-HCl pH
7.4) with 0.1% Tween 20 (TBS-T) and incubated for 30 min in a
blocking solution (5% nonfat dry milk in TBS-T; Marvel, Premier
International Foods Ltd., UK). The membranes were incubated over-
night at 4°C with primary antibodies against p-AMPKThr172, p-
ACCSer79, p-AktSer473, p-AktThr308, and p-AS160Thr642 (Cell Signal-
ing Technologies). In the morning, membranes were washed in
TBS-T and incubated with a 1:4,000 dilution of antispecies IgG
horseradish peroxidase-conjugated secondary antibodies made up in
the aforementioned blocking solution. After further washes, mem-
branes were incubated in an enhanced chemiluminescence reagent and
visualized using a chemiluminescent imager (EpiChemi II Darkroom,
UVP, Upland). Nitrocellulose membranes were then incubated for 30
min at 50°C in a stripping solution (62.5 mM Tris pH 6.7, 2% SDS,
100 mM 2-mercaptoethanol) before reblotting for total AMPK, total
ACC, total Akt2 (Cell Signaling Technologies), and total AS160
(Merck-Milliopore, UK). For these analyses, all samples from each
participant (all three trials) were run on the same gel. Band densities
were quantified using VisionWorksLS Image Acquisition and Anal-
ysis Software for Windows (UVP, Upland). For all of the signaling
molecules reported in this experiment, a ratio of phosphorylated to
total protein was calculated, and the results were expressed relative to
the baseline sample.
Substrate utilization. Expired gas samples were collected at base-
line, during the initial 2-h rest period and the OGTT at 60-min
intervals (for 5 min), and at 15-min intervals (for 1 min) during the
exercise period (or rest in BR). For all samples, participants were
provided with the mouthpiece 1 min before gas collections for a
stabilization period. Samples were collected in 200-liter Douglas bags
(Hans Rudolph, Kansas City) through falconia tubing (Baxter, Wood-
house and Taylor Ltd., Macclesfield, UK). Concurrent measures of
inspired air were made to correct for changes in ambient O2 and CO2
concentrations (7). Expired O2 and CO2 concentrations were mea-
sured in a known volume of each sample, using paramagnetic and
infrared transducers, respectively (Mini HF 5200, Servomex Group
Ltd., Crowborough, East Sussex, UK). The sensor was calibrated
using concentrations of low (99.998% N, 0% O2 and CO2) and high
(balance nitrogen mix, 16.04% O2, 5.06% CO2) calibration gases
(both BOC Industrial Gases, Linde AG, Munich, Germany). Urinary
nitrogen excretion was estimated from urine urea concentrations,
which were measured on an automated analyzer (Daytona; Randox
Laboratory, Crumlin, UK) to allow for protein oxidation to be ac-
counted for in calculations of substrate utilization rates.
Calculations and statistical analysis. A sample size estimation was
completed a priori with the total rate of plasma glucose appearance as
the primary outcome measure. Rose et al. (54) reported a difference in
the total plasma glucose appearance of (mean SD) 1,600 1,300
mol/kg during an OGTT after rest versus after fasted exercise. Using
this effect size, and an alpha level of 0.05, we calculated that 12
participants were required for an 80% probability of statistically
detecting an effect in the total rate of plasma glucose appearance
(RaTOTAL) using a crossover design with three trials and a two-tailed,
one-way ANOVA.
The total and incremental area underneath the concentration-time
curve (AUC or iAUC, respectively) for each plasma, metabolite or
hormone was calculated using the trapezoid rule. The AUC or iAUC
for each plasma metabolite or hormone was then divided by either the
duration of the total within-laboratory period (300 min) or the OGTT
observation period (120 min), as appropriate, to provide a time-
averaged value (mmol/l), which are used as summary measures.
Plasma glucose and insulin concentrations during the OGTT were
used to estimate insulin sensitivity (ISI) according to the equation of
Matsuda (41): [FPG and FPI are fasting plasma glucose and insulin
concentrations, and MPG and MPI are mean plasma glucose and
insulin concentrations in the OGTT (41)]:
ISIMATSUDAau
10,000
 FPGmgdL1 FPImIUmL1MPGmgdL1MPImIUmL1
Plasma glucose kinetics were determined using Radziuk’s two-
compartment nonsteady-state model (50, 51) and SAMM II software
(SAAM II v.2.3, The Epilson Group, Charlottesville, VA). This model
reduces errors in estimations of glucose kinetics that are apparent
when using Steele’s (56) one-compartment model (53). The RaTOTAL
and glucose disappearance (Rd) were calculated as follows:
RaTOTALt
F
E1t

V1 Gt
E1t
 E

1t k12q2ivtE1t  Q2t
(1)
Rdt RaTOTAL V1 G˙t k21 V1 Gt k12 sQ2t
(2)
where F is the [6,6-2H2] infusion, V1 is the glucose volume of
distribution [4% of body mass (kg)], E1(t) is the [2H2] plasma glucose
enrichment (mole percent excess) at time t, E˙ 1(t) is the change in E
over time (derivate of E), G(t) is the plasma glucose concentrations at
time t, G˙ (t) the change in G over time (derivate of G), k12 and k21 are
fixed rate constants between the peripheral and the accessible com-
partments (0.05/min and 0.07/min, respectively), and q2iv and Q2 are
the amounts of the tracer [2H2] and tracee in the peripheral compart-
ment, respectively, evaluated by integrating the two-compartment
model.
The [U-13C] enrichment of the orally ingested glucose and the
RaTOTAL (from Eqn. 1) were used to calculate the plasma rate of
appearance of glucose from the OGTT (RaOGTT). In these equations,
r1 is the ratio of the infusion [2H2] and oral [U-13C] glucose tracer
concentrations in plasma, r˙(t) is the change in r over time (derivate
of r), g is the [U-13C] glucose tracer in plasma, qoiv is the amount
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of the [U-13C] tracer in the peripheral compartment (by integrating
the two-compartment model), and EOGTT is the [U-13C] enrichment
of the OGTT.
raOt RaTOTALt
F
r1t

V1 gt
r1t
 r˙1t
k12q2iv(t)
r1(t)
 q2
0t (3)
RaOGTTt raOt 1EOGTT (4)
The metabolic clearance rate was calculated as the Rd divided by
the plasma glucose concentrations for a given time point (G1)
Metabolic Clearance Rate Rdt ⁄ G1 (5)
Rates of whole-body fat and carbohydrate utilization were calcu-
lated using the expired gas samples and stoichiometric equations (31).
Adjustments were made to account for the contribution made by the
oxidation of protein (estimated via urinary urea nitrogen). Plasma
glucose utilization was assumed to be equivalent to the plasma
glucose Rd as has been confirmed previously (32). Muscle glycogen
utilization during exercise (BE and FE only) was calculated as total
carbohydrate utilization during exercise minus plasma glucose utili-
zation during exercise. Because of these methods, this estimate of
muscle glycogen utilization will include the utilization of other
nonglucose carbohydrates (e.g., lactate). Both the production and
utilization of ketone bodies can influence the respiratory exchange
ratio and therefore, theoretically complicate the estimates of carbo-
hydrate oxidation during exercise. However, during short-duration,
moderate-intensity exercise this effect is negligible (31). Within-
laboratory energy expenditure was determined assuming that lip-
ids, glucose, and glycogen give 40.81, 15.64, and 17.36 kJ/g
respectively (31).
One-way, repeated measures ANOVAs were used to assess differ-
ences between trials at baseline and for summary measures (e.g.,
AUCs). If multiple comparisons were necessary, two-way repeated
measures ANOVAs (time  trial) were used to identify differences
between trials. Degrees of freedom for F values were Greenhouse-
Geisser-corrected for ε	 0.75, with Huynh-Feldt corrections used for
less severe asphericity. If time  trial interaction effects were iden-
tified, multiple paired t-tests were used to locate variance, with
Holm-Bonferroni step-wise adjustments to control for inflated type I
errors. Pearson r and Spearman R were used to explore correlations
between variables that display normal and nonnormal distribution,
respectively. Unless otherwise stated, data in text, figures, and tables
Fig. 2. The plasma glucose disposal rate (Rd)
(A), metabolic clearance rate (B), the total rate
of plasma glucose appearance (RaTOTAL) (C),
the rate of appearance of glucose in plasma
from the oral glucose tolerance test (RaOGTT)
(D), and the plasma enrichments of [2H2]-
glucose (E) and [13C]-glucose (F) before and
during an oral glucose tolerance test (OGTT)
that was conducted after breakfast followed by
rest (BREAKFAST-REST), breakfast fol-
lowed by exercise (BREAKFAST-EX), or ex-
tended overnight fasting followed by exercise
(FASTED-EX). Data are means normalized
95% confidence intervals. n 12 healthy men.
aDifference between breakfast rest vs. break-
fast exercise, bbreakfast rest vs. fasted exer-
cise, and cbreakfast exercise vs. fasted exercise
with P 	 0.05. MPE, mole percent excess.
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are means 95% confidence intervals, which were normalized by
removing between-subject variance (presented as 95% nCI) (39). All
statistical analyses were completed using IBM SPSS statistics version
22 for windows (IBM, New York), with the exception of the Holm-
Bonferroni step-wise adjustments and the calculation of normalized
confidence intervals, which were completed using Microsoft Excel
(2013). Graph Pad Prism 7 software (La Jolla, CA) was used for
preparation of the manuscript figures. A complete set of muscle
samples was only obtained from nine participants. Because of cannu-
lation difficulties, for one participant’s BR trial the last blood sample
obtained was at OGTT 70 min, and for a different participant’s BE
trial the last sample was at OGTT 60 min. For these trials (2 of 36) the
group average was used for the missing data. Sensitivity analysis was
completed for all measures involving blood samples and including/
excluding these two participants did not influence any of the primary
outcome measures. For clarity, the n is presented in all figure and table
legends.
RESULTS
Plasma glucose kinetics. The plasma glucose Rd displayed a
time  trial interaction (F  3.123, P  0.05), whereby
plasma glucose Rd was higher during exercise versus rest (Fig.
2A). Compared with extended overnight fasting, breakfast
ingestion before exercise further increased the plasma glucose
Rd during and after exercise (i.e., during the OGTT; Fig. 2A).
A main effect of the trial was detected for the plasma glucose
Rd during the OGTT (F  7.079, P  0.01), whereby the Rd
was 45 g/120 min in BR (95% nCI: 36 to 62 g/120 min) versus
73 g/120 min in BE [(95% nCI: 55 to 90 g/120 min; P  0.09
vs. BR) and 44 g/120 min in FE (95% nCI: 35 to 53 g/120
min); P  0.01 vs. BE]. Metabolic clearance rates showed a
main effect of trial, with the highest rates also apparent in BE
(Fig. 2B; F  7.849, P 	 0.01 vs. BR and FE).
A main effect of trial was detected for RaTOTAL during the
OGTT [(g/120 min); F  3.915, P  0.05], which was highest
in BE (Fig. 2C). However, after post hoc adjustment the
difference between trials was less apparent (P  0.19 for BE
vs. BR and P  0.09 for BE vs. FE). A similar pattern was
observed for the rate of appearance of glucose from the OGTT
in plasma (RaOGTT) and a trial  time interaction was detected
(Fig. 2D; F  3.134, P  0.04). A main effect of trial was
Fig. 3. Plasma glucose (A), plasma insulin
(B), plasma nonesterified fatty acids (C),
plasma 
-hydroxybuturate (D), plasma tri-
glyceride (E), and plasma intestinal fatty
acid binding protein (F) concentrations be-
fore and during an oral glucose tolerance test
(OGTT) that was conducted after breakfast
followed by rest (BREAKFAST-REST),
breakfast followed by exercise (BREAK-
FAST-EX), or extended overnight fasting
followed by exercise (FASTED-EX). Data
are means  normalized 95% confidence in-
tervals. n  12 healthy men. aDifference
between breakfast rest vs. breakfast exercise,
bbreakfast rest vs. fasted exercise, and
cbreakfast exercise vs. fasted exercise with
P 	 0.05. I-FABP, intestinal fatty acid bind-
ing protein; NEFA, nonesterified fatty acid.
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detected for the total RaOGTT (F  5.915, P  0.02), which
was 49 g/120 min in BE (95% nCI: 44 to 53 g/120 min) [65%
of the OGTT (59% to 71%)] vs. 42 g/120 min in BR [95% nCI:
36 to 46 g/120 min] [56% of the OGTT (50% to 62%); P 
0.11 vs. BE], and 41 g/120 min in FE [95% nCI: 35 to 47 g]
[55% of the OGTT (49% to 61%) P  0.06 vs. BE]. The
plasma enrichment of [2H2]- and [13C]glucose is shown in Fig.
2, E and F, respectively.
Plasma glucose concentrations. No difference between trials
was detected for plasma glucose concentrations at baseline
(Fig. 3A; P  0.05). Thereafter, a trial  time interaction was
apparent (F  2.957, P  0.01). During the exercise period
(rest in BR), plasma glucose concentrations were higher in BR
versus BE at 40 min and in BR versus FE at 50 min (both P 	
0.05). At OGTT 0 min, glucose concentrations were higher in
BR versus BE, and during the OGTT they were initially higher
in BR versus BE and in BR versus FE (all P 	 0.05), but no
further differences were then detected (Fig. 3A). Peak plasma
glucose concentrations were higher in BR versus BE (P 
0.03) but not different in BE versus FE (Table 2; P  0.05). A
main effect of the trial was detected for the within-laboratory
(300 min) glucose AUC, which was higher in BR versus BE
(Table 2; P  0.05). However, no main effect of the trial was
detected for the OGTT (120 min) iAUC (Fig. 4A; F  2.524,
P  0.11).
Plasma insulin concentrations. At baseline, there was no
difference between trials for plasma insulin concentrations
(Fig. 3B; P  0.05). Main effects of time (F  4.351, P 	
0.01) and trial (F  7.986, P 	 0.01) were detected, but there
was no trial  time interaction effect (F  2.395, P  0.07).
Peak (and time to peak) plasma insulin concentrations are
shown in Table 2. A main effect of the trial was detected for
the within-laboratory (300 min) insulin AUC, which was
higher in BR versus BE (P 	 0.01) but not different in BE
versus FE (Table 2; P  0.10). A main effect of the trial was
apparent for the insulin OGTT iAUC [Fig. 4B; (120 min)
F  5.132, P  0.02], which was lower in BE versus BR [by
27.34 pmol/l (95% nCI: 12.10 to 45.80 pmol/l); P  0.02] and
lower in BE versus FE [by 28.67 pmol/l (95% nCI: 10.21 to
47.12 pmol/l); P  0.04]. There was a main effect of trial for
the Matsuda ISI (Fig. 4C; F  22.790, P 	 0.01), which was
higher in BE versus BR [by 8.45 arbitrary units (au), (95% nCI:
6.42 to 10.47 au); P 	 0.01] and in BE versus FE [by 6.49 au
(95% nCI: 2.93 to 8.51 au); P 	 0.01].
Plasma NEFA concentrations. A main effect of the trial
(F  4.314, P  0.04) was detected for plasma NEFA at
baseline, with concentrations of 0.30 mmol/l in BR (95% nCI:
0.25 to 0.35 mmol/l), 0.45 mmol/l in BE (95% nCI: 0.36 to
0.53 mmol/l; P  0.03 BE vs. BR), and 0.36 mmol/l in FE
(95% nCI: 0.31 to 0.44 mmol/l; P  0.12 FE vs. BR and BE).
Thereafter, a time  trial interaction effect was apparent (Fig.
3C; F  11.438, P 	 0.01), where plasma NEFA concentra-
tions were lowered by breakfast consumption in BR and BE
and remained lower during the exercise in BE versus FE before
increasing during the initial OGTT period in BE and FE versus
BR. A main effect of trial was detected for the total within-
laboratory plasma NEFA (300 min) AUC and the NEFA
OGTT (120 min) AUC, which in both instances was lower in
BR versus BE and FE (Table 2; all P 	 0.01).
Other plasma metabolites. No differences were detected
between trials at baseline for plasma 
-hydroxybuturate con-
centrations (Fig. 3D; P  0.05). Thereafter, a time  trial
interaction effect was apparent (F  6.310, P 	 0.01) where
concentrations were lowered by breakfast in BR and BE.
Plasma 
-hydroxybuturate concentrations remained lower dur-
ing exercise in BE versus FE but increased during the OGTT
with BE and FE versus BR. However, with post hoc adjustment
the differences between trials for plasma 
-hydroxybuturate
concentrations became less clear (all P  0.05). The within-
laboratory (300 min) 
-hydroxybuturate AUC was lower with
BR versus BE (P  0.03) but did not differ in BE and FE
(Table 2; P  0.35). No baseline differences were detected for
Table 2. Peak plasma concentrations, time to peak concentrations, and AUC for various metabolites and hormones
measured during the total within-laboratory period and/or during an oral glucose tolerance test observation that was
conducted after Breakfast-Rest, Breakfast-Exercise, or Fasted-Exercise
Breakfast-Rest Breakfast-Exercise Fasted-Exercise
Peak glucose conc., mmol/l 10.62 (9.98, 11.25) 9.65 (9.27, 10.03)a 9.82 (9.44, 10.45) F  4.895, P  0.03
Time to peak glucose, min 36 (24, 47) 49 (36, 62) 49 (36, 61) F  2.588, P  0.12
Glucose AUCTOTAL, mmol/l 6.41 (6.21, 6.60) 6.05 (5.90, 6.15)a 6.07 (5.93, 6.27) F  6.126, P  0.01
Peak insulin conc., pmol/l 286 (231, 341) 209 (148, 269) 282 (222, 337) F  3.900, P  0.07
Time to peak insulin, min 38 (26, 49) 56 (47, 65)a 43 (33, 54) F  4.579, P  0.03
Insulin AUCTOTAL, pmol/l 88 (79, 97) 62 (54, 71)c 76 (67, 85) F  9.280, P 	 0.01
NEFA AUCTOTAL, mmol/l 0.16 (0.12, 0.19) 0.28 (0.24, 0.33)c 0.37 (0.31, 0.42)d F  24.980, P 	 0.01
NEFA AUCOGTT, mmol/l 0.10 (0.06, 0.14) 0.24 (0.20, 20.29)c 0.26 (0.22, 0.31)d F  15.510, P 	 0.01
Triglyceride AUCTOTAL, mmol/l 0.85 (0.79, 0.91) 0.81 (0.75, 0.86) 0.75 (0.70, 0.79) F  4.319, P  0.03
Triglyceride AUCOGTT, mmol/l 0.84 (0.77, 0.92) 0.79 (0.72, 0.86) 0.70 (0.64, 0.77) F  4.677, P  0.02
Lactate AUCTOTAL, mmol/l 1.05 (0.96, 1.13) 1.19 (1.08, 1.30) 1.16 (1.07, 1.27) F  3.645, P  0.06
Lactate AUCOGTT, mmol/l 1.12 (1.04, 1.20) 0.97 (0.89, 1.04)c 1.03 (0.96, 1.11) F  6.479, P  0.02

-hydroxybuturate AUCTOTAL, mmol/l 0.03 (0.00, 0.06) 0.08 (0.06, 0.13)a 0.14 (0.09, 0.19)b F  5.936, P  0.03
I-FABP AUCTOTAL, pg/ml 279 (242, 317) 304 (267, 366) 415 (353, 476)b,e F  10.870, P 	 0.01
Data are means and (normalized 95% confidence intervals); n 12 healthy men. Within-laboratory time, 300 min; oral glucose tolerance test observation time,
120 min. AUC, area under the curve; AUCTOTAL, time-averaged area underneath the concentration-time curve for the total within-laboratory period (300 min);
AUCOGTT, time-averaged area underneath the concentration-time curve for the oral glucose tolerance test (120-min); Breakfast-Rest, breakfast followed by rest;
Breakfast-Exercise, breakfast followed by exercise; conc., concentration; Fasted-Exercise, or extended overnight fasting followed by exercise; I-FABP, intestinal
fatty acid binding protein; NEFA, non-esterified fatty acid. aP 	 0.05, difference between breakfast rest and breakfast exercise; bP 	 0.05, difference between
breakfast rest and fasted exercise; cP 	 0.01, difference between breakfast rest and breakfast exercise; dP 	 0.01, difference between breakfast rest and fasted
exercise; eP 	 0.01, difference between breakfast exercise and fasted exercise.
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triglyceride concentrations (Fig. 3E, P  0.05) but a time 
trial interaction effect was apparent (F  3.994, P 	 0.01).
There was an effect of trial for the within-laboratory (300 min)
and OGTT (120 min) triglyceride AUC, which tended to be
lower in FE versus BE but with post hoc adjustment this
difference between trials was less clear (Table 2; P  0.05).
Plasma lactate concentrations at baseline were not different
across trials (P  0.05) but were lower in BR versus BE and
FE in the exercise period (rest in BR) and at OGTT 0 min but
were then higher in BR versus BE during the OGTT (time 
trial; F  20.305, P	 0.01). No effect of the trial was detected
for the total within-laboratory (300 min) lactate AUC, but a
main effect of the trial was detected for the lactate OGTT (120
min) AUC, which was higher in BR versus BE (Table 2; P 	
0.01).
Plasma I-FABP concentrations. There was no difference
between trials at baseline for plasma I-FABP concentrations
(Fig. 3F; P  0.05), but these were lower after breakfast
(time  trial interaction effect; F  6.844, P 	 0.01) in BR
and BE versus FE (both P 	 0.05). During and after
exercise (or rest in BR), I-FABP concentrations were lower
in BR and BE versus FE and remained lower in BR versus
FE until OGTT 20 min (all P 	 0.05). The within-laboratory
(300 min) I-FABP AUC was lower in BR and BE versus FE
(Table 2; P  0.01 and P  0.05, respectively).
Activation of exercise and insulin signaling pathways in
skeletal muscle. Time  trial interaction effects were apparent
for AMPKThr172 (ratio p-AMPK to total AMPK) and ACCSer79
(ratio p-ACC to total ACC) phosphorylation, if normalized to
the baseline muscle sample (Fig. 5A; F  5.154, P  0.04 and
Fig. 5B, F  5.881, P  0.02, respectively). Compared with
the BR trial, skeletal muscle AMPKThr172 phosphorylation was
higher after exercise (or after rest in BR) in the BE trial [by 1.9
fold (95% nCI: 0.9- to 2.8-fold); P 0.04] and was also higher
in BE versus the FE trial [by 1.0-fold (95% nCI: 0.2- to
2.0-fold); P  0.01]. A similar pattern was apparent for ACC
phosphorylation, which was higher after exercise (or after rest
in BR) in BE versus BR [by 6.7-fold (95% nCI: 5.4- to
8.0-fold); P  0.03] but did not differ between BE and FE
(P  0.09). By OGTT 120 min, ACCSer79 and AMPKThr172
phosphorylation had returned to baseline levels in all three
trials (all P  0.05). No time  trial interaction (F  2.110,
P  0.16) nor a main effect of trial (F  0.098, P  0.83) was
detected for AktSer473 (ratio p-AktSer473 to total-Akt2) phos-
phorylation (Fig. 6A). A main effect of time (F  9.907, P 
0.01) was observed, where AktSer473 phosphorylation was
elevated at OGTT 120 min in all trials. Similarly, no time 
trial interaction (F  1.533, P 0.25) nor a main effect of trial
(F  0.484, P  0.56) was detected for AktThr308 (ratio p-
AktThr308 to total-Akt2) phosphorylation (Fig. 6B). A main
effect of time (F  10.598, P  0.01) was also detected for
this phosphorylation site, whereby AktThr308 phosphorylation
was elevated at OGTT 120 min in all trials. For AS160Thr642
phosphorylation (ratio p-AS160Thr642 to total AS160), a
time  trial interaction was detected (Fig. 6C; F  4.430, P 
0.03), whereby the AS160Thr642 phosphorylation was not dif-
ferent between BR and BE at any time, was higher pre-OGTT
in BE compared with FE (P  0.04) but was not different
between BE and FE at 120 min post-OGTT (P  0.69).
Substrate utilization. Across the duration of the trial, carbo-
hydrate utilization was higher in BE versus BR [Fig. 7; by 514
kcal (95% nCI: 452 to 576 kcal) and higher in BE versus FE
(by 124 kcal (95% nCI: 18 to 230 kcal), both P 	 0.01]. This
difference in carbohydrate utilization between BE and FE was
derived from a higher utilization of plasma glucose and other
carbohydrate sources (i.e., primarily muscle glycogen but also
plasma lactate) in BE (P  0.02 and P  0.04, respectively).
Within-laboratory fat utilization did not differ between BR and
BE (P  0.25) but was higher in FE versus BE [by 138 kcal
(95% nCI: 6 to 224 kcal), P  0.03]. Muscle glycogen
utilization during exercise (g/kg body mass) was positively
correlated (R  0.64, P	 0.01) with skeletal muscle ACCSer79
phosphorylation (ratio p-ACC to total ACC) after exercise
conducted following BE or extended FE.
Fig. 4. The time-averaged (120 min) plasma glucose (A) and plasma insulin (B)
incremental area under the curves (iAUC) and the Matsuda insulin sensitivity
index (C) for an oral glucose tolerance test conducted after breakfast followed
by rest (BREAKFAST REST), breakfast followed by exercise (BREAKFAST
EXERCISE), or extended overnight fasting followed by exercise (FASTED
EXERCISE). Data are means  normalized 95% confidence intervals, with
individual data shown as black lines. n  12 healthy men. ISIMATSUDA,
Matsuda insulin sensitivity index.
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DISCUSSION
This is the first study, to our knowledge, to assess the effect
of preexercise feeding on postprandial plasma glucose kinetics
after exercise. Our data demonstrate that preexercise feeding
increases plasma glucose disposal during meals consumed after
exercise, despite lower insulinemia in this condition. Charac-
terizing glucose flux at meals is important because this deter-
mines postprandial glycemia, a predictor of cardiovascular
disease risk (47, 48). Previous work has only studied postpran-
dial glucose flux after fasted-state exercise. As most people
consume food and perform exercise while still in a postprandial
period from a prior meal (13, 23, 55) our results describe the
physiological responses to feeding that are more readily appli-
cable to scenarios that are representative of normal daily living.
Moreover, our novel data demonstrate that metabolic responses
to exercise conducted in an overnight fasted state and to meals
that are consumed after exercise cannot be easily extrapolated
to conditions where breakfast has been consumed.
The disposal of plasma glucose (the Rd) into skeletal muscle
is elevated after exercise, via insulin-dependent and -indepen-
dent pathways (25). We observed a higher postprandial plasma
glucose disposal rate with breakfast versus fasting before
exercise. The higher postprandial plasma glucose rate of dis-
posal with preexercise breakfast ingestion was apparent despite
lower insulinemia in the breakfast-exercise trial. At rest, break-
fast consumption improves glucose tolerance and insulin sen-
sitivity at subsequent meals [known as the “second-meal ef-
fect” (5, 20, 26)]. Mechanisms likely relate to delayed gastric
emptying (19), a potentiation of early phase insulinemia at the
second meal (37) and enhanced glucose uptake into muscle
because of increased GLUT4 trafficking (18). Our findings
show that breakfast ingestion (vs. fasting) before exercise
enhances subsequent glucose disposal at postexercise meals in
the presence of lower insulinemia, suggesting that the second-
meal effect is maintained even if exercise is performed be-
tween meals. Although the effects of preexercise feeding on
the metabolic responses during subsequent exercise is well
characterized (15, 43), our data therefore provide new insights
regarding postprandial glucose metabolism after exercise in the
fed versus fasted state.
Molecular insulin-signaling pathways are instrumental me-
diators of glucose disposal in response to exercise and/or
nutrition (11). We therefore determined the activation status of
key proteins involved in glucose uptake in skeletal muscle [the
primary site of postprandial glucose disposal (14)]. Akt acti-
vation (Thr308 and Ser473 phosphorylation) 2 h after OGTT
began, was unaffected by prior exercise or prior breakfast
ingestion. However, the timing of muscle sampling could be
responsible for this result. It is possible that differences in Akt
activation between trials may have been apparent earlier in the
postprandial period, as peak Akt phosphorylation can be vari-
able, occurring as early as 30 min after an OGTT (35). Thus,
despite the lack of a measurable difference, we cannot rule out
a role for insulin signaling in the glucose disposal responses we
observed. Distal proteins within the insulin signaling pathway
can be activated after exercise, without detectable differences
in Akt phosphorylation (61). We therefore measured
AS160Thr642 activation as this phosphorylation site has been
previously shown to be activated by both insulin and exercise
stimulation (58). However, our data show that AS160Thr642
phosphorylation was not different 2 h post-OGTT with break-
fast versus fasting before exercise, providing further evidence
that differences in early stages of the activation of the insulin
signaling pathway were not responsible for the higher plasma
Fig. 5. The phosphorylation of 5= AMP-acti-
vated protein kinase (phospho AMPKThr172,
ratio p-AMPK to total AMPK) (A) and the
phosphorylation of acetyl-CoA carboxylase
(phospho ACCSer79, ratio p-ACC to total
ACC) (B) before (PRE-OGTT) and after
(POST-OGTT) an oral glucose tolerance test
(OGTT) that was conducted after breakfast
followed by rest (BREAKFAST-REST),
breakfast followed by exercise (BREAK-
FAST-EX), or extended overnight fasting fol-
lowed by exercise (FASTED-EX). All sam-
ples were taken from the vastus lateralis. Sam-
ples were normalized to the baseline muscle
sample for each participant (collected in the
resting fasted state on the first main trial for
each participant). Data are means normal-
ized 95% confidence intervals. n  9 healthy
men. BE, Breakfast-Exercise; BR, Breakfast-
Rest; FE, Fasted-Exercise.
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glucose disposal rate we observed when breakfast was ingested
before exercise.
AMPK activity also plays a key role in muscle glucose
uptake and stimulate GLUT4 translocation (27). The greater
postexercise skeletal muscle AMPK activation with breakfast
before exercise may have contributed to the higher glucose
disposal rate in that trial. This AMPK response seems to be
specific to skeletal muscle, as we have previously shown that
postexercise adipose tissue AMPK content is unaffected by
preexercise feeding (12). The increase in skeletal muscle
AMPK activity with preexercise feeding that we report in the
present study may seem surprising given that the ingestion of
large amounts (200 g) of carbohydrate before and during
exercise can blunt AMPK signaling in muscle (3, 29). This
blunting is partly because low muscle glycogen concentrations
stimulate AMPK activity (42). The modest amount (65 g) of
carbohydrate ingested by participants in our study may explain
why we did not observe an elevated AMPK response in our
fasted-exercise trial. For example, when smaller carbohydrate
doses are ingested before and/or during exercise (~120 g or
less) the exercise induced increase in the phosphorylation of
AMPK, and ACC is not always suppressed compared with
when a placebo is ingested (2, 36, 58), although in one study
this result was apparent despite a suppression of 2-AMPK
activity when carbohydrate was ingested (2).
The heightened AMPK response observed in the current
study with breakfast before exercise may be explained by the
type of carbohydrate ingested before exercise (high-glycemic
index) in the BE trial, as this can stimulate muscle glycogen
use during exercise, especially when no carbohydrate is in-
gested during the activity (62). Thus, the high glycemic index
breakfast with a modest carbohydrate content in the present
study, may have stimulated muscle glycogen utilization during
exercise without supplying sufficient carbohydrate to replace
additional glycogen utilization, resulting in lower postexercise
muscle glycogen concentrations with breakfast versus fasting
Fig. 6. The phosphorylation of Akt2 [(A)
phospho AktSer473, ratio p-Akt Ser473 to total
Akt2 and phosphor AktThr308 (B), ratio p-
AktThr308 to total Akt2] and the phosphory-
lation of AS160 (C; AS160Thr642, ratio
p-AS160Thr642 to total AS160) before (PRE-
OGTT) and after (POST-OGTT) an oral glu-
cose tolerance test (OGTT) that was con-
ducted after breakfast followed by rest
(BREAKFAST-REST), breakfast followed
by exercise (BREAKFAST-EX), or ex-
tended overnight fasting followed by exer-
cise (FASTED-EX). All samples were taken
from the vastus lateralis. Samples were nor-
malized to the baseline muscle sample for
each participant (collected in the resting
fasted state on the first main trial for each
participant). Data are means normalized
95% confidence intervals. n  9 healthy
men. AS160, Akt substrate of 160 kDa; BE,
Breakfast-Exercise; BR, Breakfast-Rest; FE,
Fasted-Exercise.
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before exercise. This could explain the enhanced exercise-
induced AMPK response if breakfast was consumed before
exercise. However, we had insufficient tissue to measure mus-
cle glycogen concentrations in all participants, and our data
only provide rates of muscle glycogen utilization (which was
higher with feeding versus fasting before exercise). Neverthe-
less, in the two participants for whom we had sufficient tissue
to perform glycogen analyses, these data were in agreement
with the tracer-derived calculations of muscle glycogen utili-
zation (data not shown) and AMPK signaling assessed by
Western blotting. Consistent with this, the present data dem-
onstrated that postexercise ACCSer79 phosphorylation—as a
marker of activation of the AMPK pathway—positively cor-
related with muscle glycogen utilization during exercise. Thus,
taken together our results suggest that the increased postexer-
cise plasma glucose disposal rates with preexercise feeding
versus fasting may have been mediated through enhanced
AMPK signaling, which is itself a consequence of altered fuel
use during exercise. AMPK signaling and resulting muscle
glycogen concentrations following exercise after breakfast
should now be explored.
The higher plasma glucose disposal rate (despite lower
plasma insulin concentrations), which we observed in the BE
trial, may be because of differences in GLUT4 trafficking
downstream of the signaling proteins we measured. Insulin-
stimulated GLUT4 translocation and insulin sensitivity of
skeletal muscle are increased in vitro, if muscle is pretreated
with insulin, without differences in AktSer473 or AktThr308
activation, or the transport activity of GLUT4 (18). This
suggests priming of skeletal muscle by prior insulin exposure
enhances subsequent insulin action. Pretreatment with insulin
and exercise augments this response, possibly because insulin
(33) and exercise (28) stimulate GLUT4 translocation from
different intracellular stores (8, 49). As such, in the current
work, prior breakfast and exercise (the multiple stimuli in BE)
may have enhanced skeletal muscle GLUT4 translocation dur-
ing the OGTT. Although technically challenging, future work
should now quantify GLUT4 trafficking with fed versus fasted
state exercise to confirm this. It is also possible that hepatic
glucose disposal accounts for some of the increase in glucose
disposal following BE versus FE. Similarly to skeletal muscle,
insulin-stimulated hepatic glucose uptake is enhanced by prior
exposure to insulin in dogs (44, 45). Thus, assuming that this
response persists in humans and after exercise, priming of the
liver by prior breakfast could also contribute to greater glucose
disposal during meals consumed post-exercise.
The increases in postexercise glucose disposal with prior
breakfast consumption were, however, offset by alterations in
plasma glucose appearance. As such, postprandial glucose
concentrations did not differ between the two exercise trials.
Postprandial plasma glucose appearance rates are determined
by three main factors: 1) the appearance of glucose from the
meal, 2) residual appearance of glucose from previous meals,
and/or 3) liver glucose output (glycogenolysis or gluconeogen-
esis). We showed that alterations in the postprandial plasma
glucose appearance rate (RaTOTAL) after exercise with prior
breakfast was mostly driven by increased appearance of glu-
cose from the postexercise OGTT. These alterations in the
RaTOTAL suggest that differences in gut function (i.e., in-
creased intestinal damage or absorptive capacity) and/or
splanchnic blood flow altered the RaTOTAL. Therefore, break-
fast before exercise may alter postprandial glycemia via factors
related to intestinal absorption and splanchnic handling of
glucose, rather than just glucose metabolism by skeletal mus-
cle.
There are several potential mechanisms that may explain the
differences in glucose appearance rates because of intestinal
absorption and/or splanchnic handling of glucose. Plasma I-
FABP concentrations are used as a marker of damage to
intestinal epithelial cells (60). We noted lower plasma I-FABP
concentrations in the BE versus FE trial, despite increased
plasma glucose appearance rates of the orally ingested glucose
after exercise. It is therefore unlikely that increased intestinal
damage was responsible for the higher plasma glucose appear-
ance rates we observed with feeding versus fasting before
exercise. The better maintenance of splanchnic perfusion dur-
ing exercise with prior feeding is a likely explanation for this
I-FABP response (15). If splanchnic perfusion was better main-
tained during exercise with prior feeding, this may have also
directly facilitated higher OGTT-derived glucose appearance rates
in that trial versus the FE trial. It should be acknowledged,
however, that this intestinal damage response may be specific to
cycling and could differ with other exercise modalities (e.g.,
running), within the context of preexercise feeding. An alternative
mechanism for higher appearance rate of orally ingested glucose
with feeding before exercise could also be that apical glucose
transporters were primed by the prior breakfast ingestion (40).
Although further underlying mechanism(s) remain unclear, and
should therefore be investigated with future work, we showed
that a major determinant of postexercise glycemia (plasma
glucose appearance rates) are altered by preexercise feeding
and that this is unlikely to be explained by increases in
intestinal damage.
Our results show that the metabolic and intramuscular sig-
naling responses to exercise conducted in a fed state cannot be
readily inferred from responses observed with exercise in a
Fig. 7. Within-laboratory (300 min) substrate utilization after breakfast fol-
lowed by rest (BREAKFAST REST), breakfast followed by exercise
(BREAKFAST EXERCISE), or extended overnight fasting followed by exer-
cise (FASTED EXERCISE). Within-laboratory substrate utilization was cal-
culated assuming that the plasma glucose disappearance rate was equivalent to
plasma glucose utilization. Glycogen utilization during exercise (on breakfast
exercise and fasted exercise only) was calculated as total carbohydrate utili-
zation (from indirect calorimetry) minus plasma glucose utilization during
exercise. This estimate of muscle glycogen utilization will therefore include
the utilization of other nonglucose (e.g., lactate) carbohydrates. CHO, carbo-
hydrate; GLU, glucose; M-GLY, muscle glycogen; PRO, protein. Data are
presented as means  95% confidence intervals. n  12 healthy men.
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fasted state. As well as a continual investigation of the mech-
anisms responsible for differences in postprandial glucose
metabolism with altered preexercise feeding, future work
should study whether the results we observed are apparent with
different postexercise meals (including the coingestion of fat
and protein). Moreover, if the acute alterations in postprandial
metabolism translate into longer-term differences in insulin
sensitivity with repeated bouts of exercise in the fed versus
fasted state and in overweight and obese populations, should
now be a focus for future work.
To conclude, eating breakfast (vs. fasting) before exercise
increases postexercise plasma glucose disposal rates, but this is
offset by increases in appearance rates of (mainly) orally
ingested glucose, a result that does not appear to be explained
by a greater intestinal damage response to the exercise. We
showed that preexercise breakfast consumption lowers insu-
linema at meals that are consumed after exercise, providing
new evidence that the second meal effect is maintained even
when exercise is performed between eating occasions.
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